Find information on thousands of medical conditions and prescription drugs.

Burkitt's lymphoma

Burkitt's lymphoma (or "Burkitt's tumor", or "Malignant lymphoma, Burkitt's type") is a type of cancer that is associated with the Epstein-Barr virus, also the cause of mononucleosis as well as other cancers. It is named after Denis Parsons Burkitt, a surgeon who first described the disease in 1956 while working in equatorial Africa. more...

Home
Diseases
A
B
Babesiosis
Bacterial endocarditis
Bacterial food poisoning
Bacterial meningitis
Bacterial pneumonia
Balantidiasis
Bangstad syndrome
Bardet-Biedl syndrome
Bardet-Biedl syndrome
Bardet-Biedl syndrome
Bardet-Biedl syndrome
Barrett syndrome
Barth syndrome
Basal cell carcinoma
Bathophobia
Batrachophobia
Batten disease
Becker's muscular dystrophy
Becker's nevus
Behcet syndrome
Behr syndrome
Bejel
Bell's palsy
Benign congenital hypotonia
Benign essential tremor...
Benign fasciculation...
Benign paroxysmal...
Berdon syndrome
Berger disease
Beriberi
Berylliosis
Besnier-Boeck-Schaumann...
Bibliophobia
Bicuspid aortic valve
Biliary atresia
Binswanger's disease
Biotinidase deficiency
Bipolar disorder
Birt-Hogg-Dube syndrome
Blastoma
Blastomycosis
Blepharitis
Blepharospasm
Bloom syndrome
Blue diaper syndrome
Blue rubber bleb nevus
Body dysmorphic disorder
Boil
Borreliosis
Botulism
Bourneville's disease
Bowen's disease
Brachydactyly
Brachydactyly type a1
Bradykinesia
Bright's disease
Brittle bone disease
Bromidrosiphobia
Bronchiectasis
Bronchiolotis obliterans...
Bronchopulmonary dysplasia
Brown-Sequard syndrome
Brucellosis
Brugada syndrome
Bubonic plague
Budd-Chiari syndrome
Buerger's disease
Bulimia nervosa
Bullous pemphigoid
Burkitt's lymphoma
Byssinosis
Cavernous angioma
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Children affected with the disease often also had chronic malaria which is believed to have reduced resistance to the virus. This is known as classical African or endemic Burkitt's lymphoma.

Outside of central Africa, a type of non-Hodgkin's lymphoma is found where cancer cells have a similar appearance to the cancer cells of classical African or endemic Burkitt's lymphoma. This condition is known as the non-African or sporadic type of Burkitt's lymphoma. Again it is believed that impaired immunity provides an opening for development of the Epstein-Barr virus. The translocation of the myc gene is seen in this lymphoma. (t: 8;14)

Microscopy

Burkitt's lymphoma demonstrates a starry sky appearance due to the macrophage ingestion of tumor cells.

Treatment

  • Chemotherapy
    • cyclophosphamide
    • doxorubicin
    • vincristine
    • methotrexate
    • cytarabine
    • ifosfamide
    • etoposide

Read more at Wikipedia.org


[List your site here Free!]


Burkitt's lymphoma - Winchester, Virginia
From Morbidity and Mortality Weekly Report, 7/25/97

Three cases of Burkitt's lymphoma (BL) have occurred since 1971 in young boys living in one residential section of Winchester, Virginia. Onset of illness in the first 2 cases (ages 9 and 15) occurred simultaneously in August 1971 (1); the third patient (age 8) first became ill in July 1975.

The first 2 patients lived 2 houses apart and the third one-half mile away. None of the 3 patients or their families was acquainted or shared common community activities, although all 3 boys had attended the same grade school at different times. All 3 patients were Caucasian.

Manifestations of disease were similar in all 3 cases. Initial symptoms in each case involved persistent sore throat progressing to peritonsillar masses in the first 2 cases and to cervical adenopathy in the third. Histologic diagnosis of BL was made on biopsy of these masses and was confirmed on pathologic review at the National Cancer Institute. Marrow aspiration was suggestive of leukemic transformation in the third case, but not in the first 2. In each case there was clinical evidence of central nervous system (CNS) tumor involvement. Despite intensive chemotherapy in all 3 cases, and radiation therapy in 2, disease was unremitting and led to death 1, 4, and 7 months after initial diagnosis. Autopsy findings in the first 2 cases showed widespread tumor involving the CNS, as well as cervical and abdominal lymph nodes. In the third case, autopsy showed residual tumor only at the original site of occurrence (the neck). Serum antibody against Epstein Barr virus (EBV) was present at low titers in 2 cases.

Epidemiologic investigation revealed no clues to suggest a possible common etiology for these cases beyond their closeness in time and place of occurrence. Although the summers of 1971 and 1975 had somewhat greater rainfall than other years, no evidence was found to link the cases to increased mosquito or other insect exposures. No unusual local patterns of leukemia, lymphoma, or infectious mononucleosis incidence were found, and no other persons with childhood cancer were identified as having been in contact with the patients or being in their particular neighborhood. Reported by N McWilliams, MD, Medical College of Virginia; W Hatfield, MD, Lord Fairfax Health District; R Jackson, MD, State Epidemiologist, Virginia State Dept of Health; and Cancer and Birth Defects Div and Field Services Div, Bur of Epidemiology, CDC. Editorial Note: Burkitt's lymphoma is extraordinarily rare outside certain parts of central Africa and New Guinea where it constitutes the most common tumor of childhood (2). Epidemiologic surveys of childhood cancer in the metropolitan areas of Atlanta, Georgia, and Houston, Texas, suggest that the annual incidence of BL in the United States is in the range of about 1 case per million children, or an expected incidence of about 1 case every 200 years for a town the size of Winchester. In this context, the occurrence of 3 cases over 5 years in one neighborhood is distinctly unusual.

The etiologic significance of such case clustering is not clear. While early studies of African BL suggested that time-space case clustering was a common feature of the disease (3), more recent epidemiologic work has cast doubt on the idea (4). Current evidence suggests that the etiology of African BL may be related to EBV infection in a host whose immunologic state has been severely affected by constant and severe malarial infections (5). The present cases, however, provide no obvious clinical or epidemiologic clues regarding their particular etiology.

References

[1.] Levine PH, Sandler SG, Komp DM, et al: Simultaneous occurrence of "American Burkitt's Lymphoma" in neighbors. N Engl J Med 288:562-563, 1973

[2.] Wright DH: The epidemiology of Burkitt's tumor. Cancer Res 27:2424-2438, 1967

[3.] Pike MC, Williams EH, Wright B: Burkitt's tumor in the West Nile District of Uganda 1961-5. Br Med J 1:395-399, 1967

[4.] Brubaker G, Geser A, Pike MC: Burkitt's lymphoma in the North Mara district of Tanzania 1964-70: Failure to find evidence of time-space clustering in a high risk isolated rural area. Br J Cancer 28:469-472, 1973

[5.] O'Conor GT: Persistent immunologic stimulation as a factor in oncogenesis, with special reference to Burkitt's tumor. Am J Med 48:279-285, 1970

Editorial Note -- 1997: Public concern can quickly rise when persons perceive an excess of cancer in their local community. Such situations are not infrequent. Each deserves prompt public health attention to address community concerns and to explore possible etiologic clues. However, it is difficult to know when field investigations are needed and how far they should proceed. The problem is neither new nor unique to cancer because similar concerns arise about other chronic or noninfectious diseases. Cases can cluster simply by chance, and random case distributions probably account for most community case clusters. It is possible that certain clusters may have community-based causes, possibly resulting from particular patterns of infectious disease occurrence or from environmental exposures. Although methodologic problems greatly limit the exploration of such possibilities, carefully designed field investigations in selected situations should be considered (1,2).

Reports of such investigations about cancer clusters have appeared in MMWR. The two reports reprinted in this issue illustrate the diversity of analytic approaches that have been used, as well as the uncertainty of conclusions. Both of these investigations involved collaborative efforts between CDC (the Chronic Diseases Division and the Field Services Division) and local/state medical and public health authorities. In the case of acute childhood leukemia in Columbus, Ohio (3), concern was for disease frequency in the city as a whole after eight cases were diagnosed during a 3-month period -- twice the maximum number seen before. However, after further investigation, no features were observed that distinguished these cases from others, and a statistical analysis of time-space closeness indicated no evidence of unusual clustering.

The appearance of Burkitt's tumor in Winchester, Virginia, presented a different problem (4). This particular cancer is rare outside central Africa and New Guinea, and the two initial cases occurred in children whose diagnoses were simultaneous and who lived only two doors apart. The third patient, diagnosed 4 years later, lived nearby. Although no other links were found among the three cases, the rareness of the tumor, the time-space closeness of the first two cases, and the recurrent pattern suggested by the third case required consideration of alternate explanations to that of a chance event.

Interest in cancer case clusters has been evident in the medical literature since the late 19th century. Leukemia has received particular attention, perhaps because clusters suggest infectious disease outbreaks and because white cell elevations are associated with infection. The focus on leukemia intensified in the 1960s when tumor virologists, after demonstrating that leukemia viruses exist in other species, initiated an extensive search for such viruses in humans. During the 1960s and 1970s, CDC played a prominent role in that search by working closely with the National Cancer Institute in field investigations of leukemia case clusters. One of the earliest of these investigations involved eight cases of childhood leukemia in the Chicago suburb of Niles, Illinois (5). Seven of those cases were associated with one particular school where a parallel pattern of rheumatic-like illness had simultaneously appeared. The neighborhood was newly created, a situation later recalled when observations concerning a childhood leukemia cluster in the United Kingdom (UK) suggested that risk might be heightened in newly established communities (6).

Epidemiologic work continued at CDC into the 1980s, with several field investigations conducted each year in cooperation with various local and state health departments (7). Most studies involved time-space clusters of childhood leukemia cases in residential communities; however, some work involved adult leukemias, cancers of other types in both adults and children, multiple-case families, associations between human and animal cancers (i.e., pets and farm animals), and cancers occurring within acquaintance networks (e.g., former school mates). In addition, occasional situations were studied in which case clusters involved congenital malformations or chronic neurologic disease. Over time, emphasis gradually moved away from infectious disease hypotheses and increasingly focused on environmental exposures (e.g., hazardous waste sites, water pollution, and ionizing radiation).

In recent years, interest has been revived about clusters of childhood leukemia in residential communities. Much of the impetus has come from studies in the UK where a cluster of five cases occurred in a small town affecting children of men employed at a nearby nuclear fuel-reprocessing plant. Extensive epidemiologic studies confirmed this local increase in incidence and suggested a possible relation to increased paternal exposure to low levels of ionizing radiation in the workplace before the children were conceived (8).

Although studies in other human and experimental settings have not confirmed this association, nationwide studies of childhood leukemia in the UK have suggested that risk may be increased in newly settled towns, such as the one near the nuclear reprocessing plant. This observation has led to the hypothesis that infectious disease patterns among children in such new towns may be less stable than in more settled communities and may, on occasion, be reflected in unusual patterns of childhood leukemia as a rare sequel to certain infections (6). Again, this concept recalls the earlier Niles, Illinois, experience.

Despite frequent attention over the years to individual cancer case clusters and despite the various hypotheses generated, there has been no instance yet where a biologic cause for clustering has been convincingly demonstrated. In the rare instance when causation has been proven from studies of small groups of cases (9), virtually all have involved rare tumors in occupational settings where exposures were high and where reasonable evidence existed to establish individual exposure levels. The most striking example involved vinyl chloride monomer exposures causing hepatic angiosarcomas in vinyl chloride polymerization workers (10,11). No comparable set of data can be cited for exposures hypothesized in residential settings.

There are clear reasons why community cluster studies are generally inconclusive. When known carcinogens are in question (either chemicals or ionizing radiation), exposures are usually very low. Many situations, however, focus on exposures, such as nonionizing radiation, for which firm evidence of carcinogenicity is lacking at any dose. Studies also are limited by the long and irregular latency of cancer, the clinical nonspecificity of cancer cases (e.g., our inability to assign specific causes to individual cases), and the relative rareness of disease at any one point in time, resulting in very small numbers on which to base epidemiologic analyses. Nonetheless, public health departments must respond in some manner when cancer case clusters come to their attention. The first step is to respond quickly and openly so that communication with community residents is effective and concerns are not neglected. The second step is to confirm the accuracy of reported diagnoses and to compare the number of observed cases with the number to be expected. Often investigations need go no further. If more work is needed, however, the next step is either to interview affected patients or their families in search of common life features or to design and conduct a more formal epidemiologic study, usually a case-control design. Here the work may not be worth the effort unless a reasonable etiologic hypothesis exists or community concern is exceptionally high. The methodologic difficulties become all too apparent, especially the weakness of such studies, limited as they are by very small numbers. Environmental studies also should be approached with caution because of their weakness in establishing clear case-exposure relations and because of their great expense.

Despite these analytic limitations, cancer case clustering deserves research attention. With the possibility of molecular marker techniques, which in the future may help determine the etiologies of individual cancer cases, it may be possible to conduct useful studies of selected clusters, whether the hypotheses are infectious or environmental. Still, the rarity of nonchance clusters must always be considered. Area-wide statistical techniques designed to measure the degree to which cases may cluster in time and space have failed to document any consistent tendency, except perhaps in childhood cancers (12-14). if further knowledge is to develop in this difficult area of public health practice, it is among childhood cancers that work should focus (15). 1997 Editorial Note by Clark W Heath, Jr, MD, Vice President for Epidemiology and Surveillance Research, American Cancer Society, Atlanta, Georgia, and former Director Division of Chronic Diseases, Center for Disease Control. Glyn G Caldwell, MD, Clinical Coordinator, Indiana Medical Review Organization, Indianapolis, and former Chief, Cancer Branch, Bureau of Epidemiology, Center for Disease Control.

References

[1.] Heath CW Jr. Investigating causation in cancer clusters. Radiation and Environmental Biophysics 1996;35:133-6.

[2.] Bender AP, Williams AN, Johnson RA, Jagger HG. Appropriate public health responses to clusters: the art of being responsibly responsible. Am J Epidemiol 1990;132(suppl 1):S48-S52.

[3.] CDC. Acute childhood leukemia -- Columbus, Ohio. MMWR 1976;25:77-8.

[4.] CDC. Burkitt's lymphoma -- Winchester, Virginia. MMWR 1976;25:173.

[5.] Heath CW Jr, Hasterlik RJ. Leukemia among children in a suburban community. Amer J Med 1963;34:796-812.

[6.] Kinlen L, Clarke K, Hudson C. Evidence from population mixing in British New Towns 1946-1985 of an infective basis for childhood leukemia. Lancet 1990;336:577-82.

[7.] Caldwell GG, Heath CW Jr. Case clustering in cancer. South Med J 1976;69:1598-602.

[8.] Gardner MJ, Snee MP, Hall AJ, Powell CA, Downes S, Terrell JD. Results of case-control study of leukaemia and lymphoma among young people near Sellafield nuclear plant in West Cumbria. Br Med J 1990;300:423-9.

[9.] Caldwell GG. Twenty-two years of cancer cluster investigations at the CDC. Am J Epidemiol 1990;132(suppl 1):S43-S47.

[10.] Creech JL, Johnson MN. Angiosarcoma of the liver in the manufacture of polyvinyl chloride. J Occup Med 1974;16:160-1.

[11.] CDC. Epidemiologic notes and reports: angiosarcoma of the liver among polyvinyl chloride workers -- kentucky. MMWR 1997;46:97-101.

[12.] Knox G. Epidemiology of childhood leukaemia in Northumberland and Durham. Brit J Prev Soc Med 1964;18:17-24.

[13.] Mantel N. The detection of disease clustering and a generalized regression approach. Cancer Res 1967;27:209-20.

[14.] CDC. Guidelines for investigating clusters of health events. MMWR 1990;39(no. RR-11).

[15.] Alexander FE. Viruses, clusters, and clustering of childhood leukaemia: a new perspective? Eur J Cancer 1993;29A:1424-43.

Notice to Readers

Availability of Case Definitions for infectious Conditions

under Public Health Surveillance on Internet

The 1997 MMWR Recommendations and Reports, Case Definitions for Infectious Conditions under Public Health Surveillance (1), is now available on the Internet. This document provides updated uniform criteria for state health department personnel to use when reporting notifiable diseases to CDC. The reported numbers of cases of selected notifiable diseases are printed each week in Tables I-III of MMWR.

Since May 2, 1997, the complete document has been available as a .pdf file (Adobe Acrobat portable document format) from CDCS MMWR World-Wide Web (WWW) page and from CDC's file transfer protocol server at ftp.cdc.gov/. In response to high demand from state and local health departments, case definitions for specific conditions are now accessible individually from the Case Definitions for Infectious Conditions under Public Health Surveillance WWW site at http.//www.cdc.gov/epo/mmwr/ other/case_def/about.html. To facilitate analysis of historical surveillance data, the original case definitions from the 1990 publication Case Definitions for Public Health Surveillance (2) and intermediate revisions are linked at this website to their 1997 revised versions. Revisions to these case definitions will be added to this WWW site when approved by the Council of State and Territorial Epidemiologists.

References

[1.] CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997; 46(no. RR-10).

[2.] CDC. Case definitions for public health surveillance. MMWR 1990;39(no.

COPYRIGHT 1997 U.S. Government Printing Office
COPYRIGHT 2004 Gale Group

Return to Burkitt's lymphoma
Home Contact Resources Exchange Links ebay